U.S. FDA approves Gilead's hepatitis C drug for expanded use

(Reuters) - Drugmaker Gilead Sciences Inc said on Thursday the U.S. Food and Drug Administration had approved the expanded use of its blockbuster hepatitis C drug, Harvoni.